LNSR — LENSAR INC (Healthcare >> Medical Devices)
LNSR FAQ
What is LNSR's P/E ratio?
LENSAR INC (LNSR) currently trades at a P/E ratio of 1.91.
What is LNSR's ROE?
LENSAR INC reports a Return on Equity (ROE) of 119.63%.
What is LNSR's dividend yield?
LENSAR INC offers a dividend yield of 0.00%.
What is LNSR's Deepscope Quality Score?
Deepscope rates LNSR's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy LNSR?
Deepscope's AI Timing Score for LNSR is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does LNSR belong to?
LENSAR INC is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 5.62
Price
-0.12
(-2.09%)
Day Change
|
|
|---|
LNSR, the overall quality is not quite good ( Quality = 54) and the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Historical ROE is relatively low
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is not quite good , ...
| Quality Factors |
|
54% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 90 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 5.62 |
| PBV / Sector |
2.83 / 7.50
|
| Earning Per Share | 2.38 |
| PE / Sector |
1.91 / 28.68
GREAT
|
| PEG or PE/Growth / Sector |
0.07 / 0.39
GREAT
|
| Average 1M Daily Value |
0.33 M
GREAT
|
| Average 1W Daily Value |
0.25 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-05 09:12:03 |
| Symbol | LNSR |
| Name | LENSAR INC |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 12.10 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 69.48 / 18,060.39 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2800 Discovery Drive, Orlando, FL, United States, 32826
Phone: 888 536 7271
Website: https://www.lensar.com
Employees: 150
Sector: Healthcare >> Medical Devices
Description: LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
Google